SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018

February 1, 2019
Series: MMWR. Morbidity and Mortality Weekly Report ; v. 68, no. 4, p.

[PDF-68.84 KB]

English

Details Supporting Files Related Documents You May Also Like

Details:

Description:

Supplementary table for: Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018.
Series:

MMWR. Morbidity and Mortality Weekly Report ; v. 68, no. 4, p.
Document Type:

Journal Article
Genre:

Tables
Place as Subject:

United States
Volume:

68
Issue:

4
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:7e51d83dbd9cb5a988a7e368015e121d63e53d5d46a6582240d39e97833d9e2b
Download URL:

https://stacks.cdc.gov/view/cdc/62215/cdc_62215_DS1.pdf
File Type:

VAERS - Shingrix safety surveillance SUPPLEMENTARY TABLE 2.docx

docx

More +